Please use this identifier to cite or link to this item:
|Title:||Patenting and R&D in Indian Pharmaceutical Industry: Post-TRIPS Scenario|
Bedi, P M S
Sooch, Balwinder S
|Abstract:||This paper studies the impact of a restructured patent regime on the R&D expenditure and the patenting activity of Indian pharmaceutical companies. The results indicate that there is an increase in both R&D investment and measured inventive output in the form of patents. The firms, which have paid very little attention to research and innovation in the past, are responding to the restructured IPR regime in novel ways. However, this effect appears to be highly concentrated in the technologically progressive large scale pharmaceuticals while SMEs are yet to develop or acquire resources in order to survive in this competitive era.|
|ISSN:||0975-1076 (Online); 0971-7544 (Print)|
|Appears in Collections:||JIPR Vol.18(2) [March 2013]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.